US › Healthcare

The Joint Corp (JYNT)

US · Healthcare · Medical Care Facilities

$7.03+1.74%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$15.2M

Revenue YoY

+14.4%

Net profit

$653,021

Profit YoY

+599.4%

EPS

$-0.01

EPS estimate

$0.11

Net margin

4.3%

EPS came in at -0.01 against a street estimate of 0.11 — a miss of 109.1%.

Key statistics

Market cap

$98.6M

P/E

49.8

Forward P/E

11.9

P/B

7.45

Book value

$1.16

EPS (TTM)

$0.14

52-week high

$10.67

52-week low

$6.79

50-day MA

$8.11

200-day MA

$8.72

Beta

1.09

Analyst view

Analysts rate The Joint Corp a buy (1 buy, 3 hold, 0 sell out of 4) with an average price target of $10.00.

Shareholding

Insiders

16.23%

Institutions

69.28%

Largest institutional holders

Fund	Stake
Bandera Partners LLC	27.84%
Skylands Capital, LLC	6.33%
JCP Investment Management, LLC	4.20%
Vanguard Capital Management, LLC	3.94%
Keller Group Invmt Management Inc	2.37%
BlackRock Inc	2.04%
Jane Street Group LLC	1.67%
Vanguard Portfolio Management, LLC	1.59%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for The Joint Corp — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.